Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 286 articles: HTML format

Single Articles

April 2021
1. KALYANI RR
   Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
   N Engl J Med. 2021;384:1248-1260.
   PubMed    
   
   
   March 2021
2. KIM ESH
   Spontaneous Coronary-Artery Dissection. Reply.
   N Engl J Med. 2021;384:1077-1078.
   PubMed    
   
   
   
3. WANG X, Ge J
   Spontaneous Coronary-Artery Dissection.
   N Engl J Med. 2021;384:1077.
   PubMed    
   
   
   
4. CAMPOCHIARO C, Tomelleri A, Dagna L
   Spontaneous Coronary-Artery Dissection.
   N Engl J Med. 2021;384:1077.
   PubMed    
   
   
   
5. GIBBONS GH, Seidman CE, Topol EJ
   Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
   N Engl J Med. 2021;384:785-788.
   PubMed    
   
   
   February 2021
6. FIOLET ATL, Cornel JH, Thompson PL
   Colchicine in Patients with Chronic Coronary Disease. Reply.
   N Engl J Med. 2021;384:778-779.
   PubMed    
   
   
   
7. D'AMARIO D, Rodolico D, Galli M
   Colchicine in Patients with Chronic Coronary Disease.
   N Engl J Med. 2021;384:778.
   PubMed    
   
   
   
8. LUCIJANIC M, Javor E, Skelin M
   Colchicine in Patients with Chronic Coronary Disease.
   N Engl J Med. 2021;384:777-778.
   PubMed    
   
   
   
9. FISCHER BG
   Colchicine in Patients with Chronic Coronary Disease.
   N Engl J Med. 2021;384:777.
   PubMed    
   
   
   
10. GEBHARD C, Regitz-Zagrosek V
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776-777.
    PubMed    
    
    
    
11. KAISER D, Jackson CD
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776.
    PubMed    
    
    
    
12. JENKINS DJA, Dehghan M, Mente A, Bangdiwala SI, et al
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2007123.
    PubMed     Abstract available
    
    
    
13. RODRIGUEZ F, Harrington RA
    Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:452-460.
    PubMed    
    
    
    January 2021
14. HUFFMAN MD, Patel A
    Polypills - A Central Strategy for Improving Cardiovascular Health.
    N Engl J Med. 2021;384:288-289.
    PubMed    
    
    
    
15. SCOTT NS, Thomas SS, DeFaria Yeh D, Fox AS, et al
    Case 2-2021: A 26-Year-Old Pregnant Woman with Ventricular Tachycardia and Shock.
    N Engl J Med. 2021;384:272-282.
    PubMed    
    
    
    December 2020
16. KIM ESH
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2020;383:2358-2370.
    PubMed    
    
    
    November 2020
17. YUSUF S, Joseph P, Dans A, Gao P, et al
    Polypill with or without Aspirin in Persons without Cardiovascular Disease.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028220.
    PubMed     Abstract available
    
    
    October 2020
18. LEE TH
    Seizing the Teachable Moment - Lessons from Eisenhower's Heart Attack.
    N Engl J Med. 2020;383:e100.
    PubMed    
    
    
    
19. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    PubMed    
    
    
    September 2020
20. CANNON CP, Pratley R, Dagogo-Jack S, Mancuso J, et al
    Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMoa2004967.
    PubMed     Abstract available
    
    
    
21. BANGALORE S, Maron DJ, Hochman JS
    Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply.
    N Engl J Med. 2020;383:1091-1092.
    PubMed    
    
    
    
22. YING T, Gill JS, Chadban S
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1091.
    PubMed    
    
    
    
23. AFSAR B, Elsurer Afsar R, Kanbay M
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090-1091.
    PubMed    
    
    
    
24. SHETTY HB, Shetty AH
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090.
    PubMed    
    
    
    
25. WEBSTER MWI, Stewart RAH
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090.
    PubMed    
    
    
    
26. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury. Reply.
    N Engl J Med. 2020;383:1094.
    PubMed    
    
    
    
27. CHALIKIAS G, Tziakas D
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;383:1094.
    PubMed    
    
    
    
28. BURTSCHER J, Millet GP, Burtscher M
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;383:1093.
    PubMed    
    
    
    
29. ANTMAN EM, Braunwald E
    Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    
30. MARON DJ, Hochman JS
    Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    
31. KARIMI GALOUGAHI K, Patel S, Adams M
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    
32. VAN 'T HOF A, Crea F
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    
33. VAN MIEGHEM NM, Daemen J, Zijlstra F
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    
34. TOMODA H
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    
35. DANGAS G, Roumeliotis A, Giustino G
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    PubMed    
    
    
    August 2020
36. NIDORF SM, Fiolet ATL, Mosterd A, Eikelboom JW, et al
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372.
    PubMed     Abstract available
    
    
    
37. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2022190.
    PubMed     Abstract available
    
    
    
38. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    PubMed     Abstract available
    
    
    
39. SCOTT AC, McDonald A, Roberts T, Martin C, et al
    Cardiovascular Telemedicine Program in Rural Australia.
    N Engl J Med. 2020;383:883-884.
    PubMed    
    
    
    
40. VERGALLO R, Crea F
    Atherosclerotic Plaque Healing.
    N Engl J Med. 2020;383:846-857.
    PubMed    
    
    
    
41. FERENCE BA, Ray KK, Nicholls SJ
    Mendelian Randomization Study of ACLY and Cardiovascular Disease. Reply.
    N Engl J Med. 2020;383:e50.
    PubMed    
    
    
    
42. HOLM H, Sulem P, Helgadottir A, Tragante V, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    PubMed    
    
    
    
43. DAMASK A, Paulding C, Baras A, Carey D, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    PubMed    
    
    
    
44. KLARIN D, O'Donnell CJ, Kathiresan S
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    PubMed    
    
    
    July 2020
45. STONE GW, Serruys PW, Sabik JF
    PCI or CABG for Left Main Coronary Artery Disease. Reply.
    N Engl J Med. 2020;383:292-294.
    PubMed    
    
    
    
46. BAKAEEN FG, Svennson LG
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:292.
    PubMed    
    
    
    
47. KAPOOR S, Mulukutla S
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291-292.
    PubMed    
    
    
    
48. LOPEZ-AYALA P, Koechlin L, Mueller C
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291.
    PubMed    
    
    
    
49. LOZANO I, Rondan J, Vegas JM
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290-291.
    PubMed    
    
    
    
50. TAGGART DP, Gaudino M
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290.
    PubMed    
    
    
    
51. NEWTON-CHEH C, Zlotoff DA, Hung J, Rupasov A, et al
    Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMcpc2004975.
    PubMed    
    
    
    June 2020
52. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;382:2238-2247.
    PubMed    
    
    
    
53. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 4. doi: 10.1056/NEJMc2021225.
    PubMed    
    
    
    
54. RUBIN EJ
    Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 2. doi: 10.1056/NEJMe2020822.
    PubMed    
    
    
    May 2020
55. HIGANO CS
    Cardiovascular Disease and Androgen Axis-Targeted Drugs for Prostate Cancer.
    N Engl J Med. 2020 May 29. doi: 10.1056/NEJMe2016433.
    PubMed    
    
    
    
56. TSIMIKAS S, Karwatowska-Prokopczuk E, Xia S
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply.
    N Engl J Med. 2020;382:e65.
    PubMed    
    
    
    
57. FERRO CJ, Sarafidis P, Ortiz A
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    
    
    
    
58. ANDREOTTI F, Maggioni AP
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    
    
    
    
59. ALKHALIL M
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    PubMed    
    
    
    
60. SOLOMON MD, McNulty EJ, Rana JS, Leong TK, et al
    The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMc2015630.
    PubMed    
    
    
    
61. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2007621.
    PubMed     Abstract available
    
    
    April 2020
62. DE FILIPPO O, D'Ascenzo F, Angelini F, Bocchino PP, et al
    Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009166.
    PubMed    
    
    
    
63. TARDIF JC, L'Allier PL, Guertin MC
    Low-Dose Colchicine after Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1668.
    PubMed    
    
    
    
64. CHIARITO M, Condorelli G, Stefanini GG
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667-1668.
    PubMed    
    
    
    
65. REINDL M, Metzler B, Reinstadler SJ
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667.
    PubMed    
    
    
    
66. FURER V, Elkayam O, Caspi D
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1666-1667.
    PubMed    
    
    
    
67. KITTLESON MM
    The Invisible Hand - Medical Care during the Pandemic.
    N Engl J Med. 2020;382:1586-1587.
    PubMed    
    
    
    
68. SPERTUS JA, Jones PG, Maron DJ, Mark DB, et al
    Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
    N Engl J Med. 2020;382:1619-1628.
    PubMed     Abstract available
    
    
    
69. BANGALORE S, Sharma A, Slotwiner A, Yatskar L, et al
    ST-Segment Elevation in Patients with Covid-19 - A Case Series.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009020.
    PubMed    
    
    
    
70. MEHTA SR, Wood DA, Cairns JA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1571-1572.
    PubMed    
    
    
    
71. DOENST T, Boning A, Thiele H
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1571.
    PubMed    
    
    
    
72. FERREIRA RM, Salis LHA, de Souza E Silva NA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1570.
    PubMed    
    
    
    
73. BURGESS SN, Juergens CP, French JK
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569-1570.
    PubMed    
    
    
    
74. DESCHNER M, Glanz A
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    PubMed    
    
    
    
75. AUER J, Berent R, Gurtner F
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    PubMed    
    
    
    
76. BOGATY P, Brophy JM
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1568.
    PubMed    
    
    
    
77. RAY KK, Wright RS, Kallend D, Koenig W, et al
    Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
    N Engl J Med. 2020;382:1507-1519.
    PubMed     Abstract available
    
    
    March 2020
78. BANGALORE S, Maron DJ, O'Brien SM, Fleg JL, et al
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915925.
    PubMed     Abstract available
    
    
    
79. MARON DJ, Hochman JS, Reynolds HR, Bangalore S, et al
    Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915922.
    PubMed     Abstract available
    
    
    
80. SPERTUS JA, Jones PG, Maron DJ, O'Brien SM, et al
    Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1916370.
    PubMed     Abstract available
    
    
    
81. ANTMAN EM, Braunwald E
    Managing Stable Ischemic Heart Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMe2000239.
    PubMed    
    
    
    
82. WINDECKER S, Latib A, Kedhi E, Kirtane AJ, et al
    Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
    N Engl J Med. 2020;382:1208-1218.
    PubMed     Abstract available
    
    
    
83. 
    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2020;382:1078.
    PubMed    
    
    
    
84. BOHOSSIAN HB, Lopes EW, Roller LA, Ananthakrishnan AN, et al
    Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
    N Engl J Med. 2020;382:1042-1052.
    PubMed    
    
    
    February 2020
85. OLENSKI AR, Zimerman A, Coussens S, Jena AB, et al
    Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery.
    N Engl J Med. 2020;382:778-779.
    PubMed    
    
    
    January 2020
86. SCHUPKE S, Kastrati A
    Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply.
    N Engl J Med. 2020;382:487.
    PubMed    
    
    
    
87. SHARMA S, Lardizabal J, Sharma R
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:487.
    PubMed    
    
    
    
88. CARBONELL-PRAT B, Flores-Umanzor E, Brugaletta S
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:486.
    PubMed    
    
    
    
89. WANG TJ, Munoz D, Blot WJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.
    N Engl J Med. 2020;382:95.
    PubMed    
    
    
    
90. BILAL U, Cainzos-Achirica M
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94-95.
    PubMed    
    
    
    
91. BRUGTS JJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94.
    PubMed    
    
    
    
92. TSIMIKAS S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, et al
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020 Jan 1. doi: 10.1056/NEJMoa1905239.
    PubMed     Abstract available
    
    
    December 2019
93. NEUMANN JT, Twerenbold R, Blankenberg S
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. Reply.
    N Engl J Med. 2019;381:2483.
    PubMed    
    
    
    
94. AKSOY A, Agirbasli M
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482-2483.
    PubMed    
    
    
    
95. LAU CS, Aw TC
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482.
    PubMed    
    
    
    
96. YASUDA S, Ogawa H
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Reply.
    N Engl J Med. 2019;381:2481.
    PubMed    
    
    
    
97. GREMMEL T
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480-2481.
    PubMed    
    
    
    
98. PATTI G, De Caterina R
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480.
    PubMed    
    
    
    
99. MARQUIS-GRAVEL G, Roe MT
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2479-2480.
    PubMed    
    
    
    
100. PANZA JA, Velazquez EJ, Bonow RO
     Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. Reply.
     N Engl J Med. 2019;381:2374.
     PubMed    
     
     
     
101. SHARMA S, Sharma R, Lardizabal J
     Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
     N Engl J Med. 2019;381:2373.
     PubMed    
     
     
     
102. NAPP LC, Bengel FM, Bauersachs J
     Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
     N Engl J Med. 2019;381:2373.
     PubMed    
     
     
     
103. NAGEL E, Berry C
     Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. Reply.
     N Engl J Med. 2019;381:2277-2278.
     PubMed    
     
     
     
104. TEBALDI M, Biscaglia S, Campo G
     Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
     N Engl J Med. 2019;381:2277.
     PubMed    
     
     
     
105. DESCHNER M, Glanz A
     Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
     N Engl J Med. 2019;381:2276-2277.
     PubMed    
     
     
     
106. O'ROURKE MF, Adji A
     Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
     N Engl J Med. 2019;381:2276.
     PubMed    
     
     
     November 2019
107. HUSAIN M, Donsmark M, Bain SC
     Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
     N Engl J Med. 2019;381:2076-2077.
     PubMed    
     
     
     
108. ZWECK E, Westenfeld R, Szendroedi J
     Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2019;381:2075-2076.
     PubMed    
     
     
     
109. MEHRAN R, Baber U, Sharma SK, Cohen DJ, et al
     Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
     N Engl J Med. 2019;381:2032-2042.
     PubMed     Abstract available
     
     
     
110. TARDIF JC, Kouz S, Waters DD, Bertrand OF, et al
     Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
     N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1912388.
     PubMed     Abstract available
     
     
     
111. NEWBY LK
     Inflammation as a Treatment Target after Acute Myocardial Infarction.
     N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMe1914378.
     PubMed    
     
     
     October 2019
112. 
     Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
     N Engl J Med. 2019;381:1789.
     PubMed    
     
     
     
113. BRIOSA E GALA A, Rawlins J
     Posterior-Wall Myocardial Infarction.
     N Engl J Med. 2019;381:e32.
     PubMed    
     
     
     
114. FLINT AC, Conell C, Bhatt DL
     Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. Reply.
     N Engl J Med. 2019;381:1692-1693.
     PubMed    
     
     
     
115. VERDECCHIA P, Angeli F, Reboldi G
     Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
     N Engl J Med. 2019;381:1691-1692.
     PubMed    
     
     
     
116. QUINN S, McEvoy JW
     Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
     N Engl J Med. 2019;381:1690-1691.
     PubMed    
     
     
     
117. KOSTIS WJ, Kostis JB, Moreyra AE
     Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
     N Engl J Med. 2019;381:1690.
     PubMed    
     
     
     
118. BERNSTEIN SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, et al
     Case 33-2019: A 35-Year-Old Woman with Cardiopulmonary Arrest during Cesarean Section.
     N Engl J Med. 2019;381:1664-1673.
     PubMed    
     
     
     
119. CLAASSENS DMF, Vos GJA, Bergmeijer TO, Hermanides RS, et al
     A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
     N Engl J Med. 2019;381:1621-1631.
     PubMed     Abstract available
     
     
     
120. JNEID H
     Ticagrelor or Prasugrel in Acute Coronary Syndromes - The Winner Takes It All?
     N Engl J Med. 2019;381:1582-1585.
     PubMed    
     
     
     
121. MICHOS ED, McEvoy JW, Blumenthal RS
     Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
     N Engl J Med. 2019;381:1557-1567.
     PubMed    
     
     
     
122. KOBER L, Engstrom T
     A More COMPLETE Picture of Revascularization in STEMI.
     N Engl J Med. 2019;381:1472-1474.
     PubMed    
     
     
     September 2019
123. STONE GW, Kappetein AP, Sabik JF, Pocock SJ, et al
     Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
     N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406.
     PubMed     Abstract available
     
     
     
124. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
     Polypill for Cardiovascular Disease Prevention in an Underserved Population.
     N Engl J Med. 2019;381:1114-1123.
     PubMed     Abstract available
     
     
     
125. YASUDA S, Kaikita K, Akao M, Ako J, et al
     Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
     N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMoa1904143.
     PubMed     Abstract available
     
     
     
126. BECKER RC
     Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease.
     N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMe1910560.
     PubMed    
     
     
     
127. STEG PG, Bhatt DL, Simon T, Fox K, et al
     Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
     N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908077.
     PubMed     Abstract available
     
     
     
128. BATES ER
     Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes.
     N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMe1910813.
     PubMed    
     
     
     
129. MEHTA SR, Wood DA, Storey RF, Mehran R, et al
     Complete Revascularization with Multivessel PCI for Myocardial Infarction.
     N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1907775.
     PubMed     Abstract available
     
     
     
130. SCHUPKE S, Neumann FJ, Menichelli M, Mayer K, et al
     Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
     N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908973.
     PubMed     Abstract available
     
     
     August 2019
131. PANZA JA, Ellis AM, Al-Khalidi HR, Holly TA, et al
     Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
     N Engl J Med. 2019;381:739-748.
     PubMed     Abstract available
     
     
     July 2019
132. HARDIN CC, Malhotra R, Petranovic M, Klassen S, et al
     Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia.
     N Engl J Med. 2019;381:359-369.
     PubMed    
     
     
     
133. FLINT AC, Conell C, Ren X, Banki NM, et al
     Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
     N Engl J Med. 2019;381:243-251.
     PubMed     Abstract available
     
     
     
134. LEMKES JS, Janssens GN, van Royen N
     Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. Reply.
     N Engl J Med. 2019;381:189-190.
     PubMed    
     
     
     
135. DE SILVA K, Perera D
     Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
     N Engl J Med. 2019;381:189.
     PubMed    
     
     
     
136. KIM YJ, Kim WY
     Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
     N Engl J Med. 2019;381:189.
     PubMed    
     
     
     
137. WALDMANN V, Bonnet G, Spaulding C
     Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
     N Engl J Med. 2019;381:188-189.
     PubMed    
     
     
     
138. DEGRELL P, Varenne O
     Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
     N Engl J Med. 2019;381:188.
     PubMed    
     
     
     June 2019
139. NEUMANN JT, Twerenbold R, Ojeda F, Sorensen NA, et al
     Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
     N Engl J Med. 2019;380:2529-2540.
     PubMed     Abstract available
     
     
     
140. NAGEL E, Greenwood JP, McCann GP, Bettencourt N, et al
     Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
     N Engl J Med. 2019;380:2418-2428.
     PubMed     Abstract available
     
     
     
141. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
     Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
     PubMed     Abstract available
     
     
     
142. RIDKER PM
     Methotrexate for Prevention of Cardiovascular Events. Reply.
     N Engl J Med. 2019;380:2277.
     PubMed    
     
     
     
143. HUANG Y, Chan AW, Shear NH
     Methotrexate for Prevention of Cardiovascular Events.
     N Engl J Med. 2019;380:2277.
     PubMed    
     
     
     
144. VAN VOLLENHOVEN RF, Nurmohamed M
     Methotrexate for Prevention of Cardiovascular Events.
     N Engl J Med. 2019;380:2276-2277.
     PubMed    
     
     
     May 2019
145. DE LA FUENTE J, Bird J
     Coronary Arteritis in IgG4-Related Disease.
     N Engl J Med. 2019;380:2156.
     PubMed    
     
     
     
146. YU D, Blair JEA
     A STEMI Mimic.
     N Engl J Med. 2019;380:e41.
     PubMed    
     
     
     
147. SCHWARTZ GG, Steg PG, Szarek M
     Alirocumab after Acute Coronary Syndrome. Reply.
     N Engl J Med. 2019;380:2077.
     PubMed    
     
     
     
148. PIGNATELLI P, Camera M, Violi F
     Alirocumab after Acute Coronary Syndrome.
     N Engl J Med. 2019;380:2076.
     PubMed    
     
     
     
149. ENNEZAT PV, Hansen MR
     Alirocumab after Acute Coronary Syndrome.
     N Engl J Med. 2019;380:2076.
     PubMed    
     
     
     
150. LAN NSR, Yeap BB, Fegan PG
     Alirocumab after Acute Coronary Syndrome.
     N Engl J Med. 2019;380:2075-2076.
     PubMed    
     
     
     
151. ALKHALIL M
     Alirocumab after Acute Coronary Syndrome.
     N Engl J Med. 2019;380:2075.
     PubMed    
     
     
     
152. GAO Y, Hou B
     Alirocumab after Acute Coronary Syndrome.
     N Engl J Med. 2019;380:2074-2075.
     PubMed    
     
     
     
153. THIELE H, Schneider S, Desch S
     One-Year Outcomes after PCI Strategies in Cardiogenic Shock. Reply.
     N Engl J Med. 2019;380:1877.
     PubMed    
     
     
     
154. YAN F, Thall P, Yuan Y
     One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
     N Engl J Med. 2019;380:1876-1877.
     PubMed    
     
     
     
155. WIVIOTT SD, Raz I, Sabatine MS
     Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
     N Engl J Med. 2019;380:1881-1882.
     PubMed    
     
     
     
156. AKINCI B
     Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2019;380:1881.
     PubMed    
     
     
     
157. BAGLIONI P
     Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2019;380:1880-1881.
     PubMed    
     
     
     April 2019
158. BHATT DL, Steg PG, Miller M
     Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
     N Engl J Med. 2019;380:1678.
     PubMed    
     
     
     
159. BORGHI C, Fogacci F, Cicero AFG
     Cardiovascular Risk Reduction with Icosapent Ethyl.
     N Engl J Med. 2019;380:1678.
     PubMed    
     
     
     
160. CHAN LN
     Cardiovascular Risk Reduction with Icosapent Ethyl.
     N Engl J Med. 2019;380:1677.
     PubMed    
     
     
     
161. MUSHER DM, Abers MS, Corrales-Medina VF
     Acute Infection and Myocardial Infarction. Reply.
     N Engl J Med. 2019;380.
     PubMed    
     
     
     
162. FRANK RC, Hanidziar D
     Acute Infection and Myocardial Infarction.
     N Engl J Med. 2019;380.
     PubMed    
     
     
     March 2019
163. LANDONI G, Lomivorotov VV, Nigro Neto C, Monaco F, et al
     Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
     N Engl J Med. 2019 Mar 19. doi: 10.1056/NEJMoa1816476.
     PubMed     Abstract available
     
     
     
164. LEMKES JS, Janssens GN, van der Hoeven NW, Jewbali LSD, et al
     Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
     N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1816897.
     PubMed     Abstract available
     
     
     
165. ABELLA BS, Gaieski DF
     Coronary Angiography after Cardiac Arrest - The Right Timing or the Right Patients?
     N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMe1901651.
     PubMed    
     
     
     
166. LOPES RD, Heizer G, Aronson R, Vora AN, et al
     Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
     N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1817083.
     PubMed     Abstract available
     
     
     
167. MEHTA SR
     Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
     N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMe1902214.
     PubMed    
     
     
     
168. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
     Mendelian Randomization Study of ACLY and Cardiovascular Disease.
     N Engl J Med. 2019;380:1033-1042.
     PubMed     Abstract available
     
     
     
169. OH J, Kang SM
     Rivaroxaban in Patients with Heart Failure.
     N Engl J Med. 2019;380:988.
     PubMed    
     
     
     February 2019
170. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
     Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
     N Engl J Med. 2019;380:752-762.
     PubMed     Abstract available
     
     
     
171. FAUCHIER L, Clementy N, Bisson A
     Wearable Cardioverter-Defibrillator after Myocardial Infarction.
     N Engl J Med. 2019;380:600.
     PubMed    
     
     
     
172. STECKER EC, Walsh MN
     Wearable Cardioverter-Defibrillator after Myocardial Infarction.
     N Engl J Med. 2019;380:599.
     PubMed    
     
     
     
173. 
     Wearable Cardioverter-Defibrillator after Myocardial Infarction.
     N Engl J Med. 2019;380:599-601.
     PubMed    
     
     
     January 2019
174. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
     Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
     N Engl J Med. 2019;380:437-446.
     PubMed     Abstract available
     
     
     
175. 
     Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
     N Engl J Med. 2019;380:298-300.
     PubMed    
     
     
     
176. CHEUNG BMY
     Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
     N Engl J Med. 2019;380:299-300.
     PubMed    
     
     
     
177. SANDHU AT, Maron DJ
     Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
     N Engl J Med. 2019;380:299.
     PubMed    
     
     
     
178. BOGATY P, Brophy J
     Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
     N Engl J Med. 2019;380:298-9.
     PubMed    
     
     
     
179. KOROSOGLOU G, Giusca S
     Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
     N Engl J Med. 2019;380:298.
     PubMed    
     
     
     
180. MUSHER DM, Abers MS, Corrales-Medina VF
     Acute Infection and Myocardial Infarction.
     N Engl J Med. 2019;380:171-176.
     PubMed    
     
     
     
181. VERMA S, Mazer CD
     Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
     N Engl J Med. 2019;380:189-191.
     PubMed    
     
     
     December 2018
182. MATSUURA H, Ohya M
     Coronary-Artery Occlusion from Kawasaki's Disease.
     N Engl J Med. 2018;379:e42.
     PubMed    
     
     
     
183. WADHERA RK, Bhatt DL
     Toward Precision Policy - The Case of Cardiovascular Care.
     N Engl J Med. 2018;379:2193-2195.
     PubMed    
     
     
     November 2018
184. BURNETT JR, Hooper AJ
     PCSK9 - A Journey to Cardiovascular Outcomes.
     N Engl J Med. 2018;379:2161-2162.
     PubMed    
     
     
     
185. KOPJAR T, Gasparovic H, Biocina B
     Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
     N Engl J Med. 2018;379:1966-7.
     PubMed    
     
     
     
186. REHMAN SM, Duggan SMJ
     Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
     N Engl J Med. 2018;379:1966.
     PubMed    
     
     
     
187. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
     Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
     N Engl J Med. 2018;379:1966.
     PubMed    
     
     
     
188. 
     Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
     N Engl J Med. 2018;379:1966-1968.
     PubMed    
     
     
     
189. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
     Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
     N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
     PubMed     Abstract available
     
     
     
190. MANSON JE, Cook NR, Lee IM, Christen W, et al
     Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
     N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
     PubMed     Abstract available
     
     
     
191. MANSON JE, Cook NR, Lee IM, Christen W, et al
     Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
     N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
     PubMed     Abstract available
     
     
     
192. BHATT DL, Steg PG, Miller M, Brinton EA, et al
     Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
     N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
     PubMed     Abstract available
     
     
     
193. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
     Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
     PubMed     Abstract available
     
     
     
194. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
     Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
     N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
     PubMed     Abstract available
     
     
     
195. ADRIAENSSENS T, Van de Werf F
     Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
     N Engl J Med. 2018;379:1775-1776.
     PubMed    
     
     
     
196. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
     One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
     N Engl J Med. 2018;379:1699-1710.
     PubMed     Abstract available
     
     
     October 2018
197. 
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1582-1584.
     PubMed    
     
     
     
198. MONTENEGRO MF, Lundberg JO, Weitzberg E
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1583-4.
     PubMed    
     
     
     
199. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1583.
     PubMed    
     
     
     
200. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1582.
     PubMed    
     
     
     
201. DRAZEN JM
     Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
     N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
     PubMed    
     
     
     
202. 
     Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
     N Engl J Med. 2018;379:1486.
     PubMed    
     
     
     
203. 
     Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
     N Engl J Med. 2018;379:1387-1389.
     PubMed    
     
     
     
204. STEWART RAH
     Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
     N Engl J Med. 2018;379:1388.
     PubMed    
     
     
     
205. JENKINS D, Sievenpiper J, Jones P
     Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
     N Engl J Med. 2018;379:1387-8.
     PubMed    
     
     
     
206. CORREIA LCL
     Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
     N Engl J Med. 2018;379:1387.
     PubMed    
     
     
     September 2018
207. FIELD ME, Page RL
     Another Shock for Sudden Death Prevention after Myocardial Infarction.
     N Engl J Med. 2018;379:1274-1275.
     PubMed    
     
     
     
208. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
     Wearable Cardioverter-Defibrillator after Myocardial Infarction.
     N Engl J Med. 2018;379:1205-1215.
     PubMed     Abstract available
     
     
     
209. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
     Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
     N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
     PubMed     Abstract available
     
     
     August 2018
210. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
     Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
     N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
     PubMed     Abstract available
     
     
     
211. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
     Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
     N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
     PubMed     Abstract available
     
     
     
212. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
     Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
     N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
     PubMed     Abstract available
     
     
     
213. 
     Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
     N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
     PubMed     Abstract available
     
     
     
214. HOFFMANN U, Udelson JE
     Imaging Coronary Anatomy and Reducing Myocardial Infarction.
     N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
     PubMed    
     
     
     
215. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
     Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
     N Engl J Med. 2018;379:633-644.
     PubMed     Abstract available
     
     
     
216. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
     Case 25-2018: A 63-Year-Old Man with Syncope.
     N Engl J Med. 2018;379:670-680.
     PubMed    
     
     
     July 2018
217. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
     Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
     N Engl J Med. 2018;379:250-259.
     PubMed     Abstract available
     
     
     June 2018
218. CUERVO G, Viasus D, Carratala J
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:2540.
     PubMed    
     
     
     
219. BUCKLEY LF
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:2539-40.
     PubMed    
     
     
     
220. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:2539.
     PubMed    
     
     
     
221. WIESSMAN M, Shlomai A
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:2539.
     PubMed    
     
     
     
222. WAXMAN DA, Kanzaria HK, Schriger DL
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:2538-9.
     PubMed    
     
     
     
223. 
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:2538-2541.
     PubMed    
     
     
     
224. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
     Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
     N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
     PubMed    
     
     
     
225. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
     Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
     N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
     PubMed     Abstract available
     
     
     
226. ARBOINE L, Palacios JM
     Left Main Coronary Artery Aneurysm.
     N Engl J Med. 2018;378:e32.
     PubMed    
     
     
     May 2018
227. SHAPIRA OM
     Radial Artery as the Preferred Second Conduit for Coronary Bypass.
     N Engl J Med. 2018;378:2134-2135.
     PubMed    
     
     
     
228. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
     Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
     N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
     PubMed     Abstract available
     
     
     April 2018
229. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
     Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
     N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
     PubMed     Abstract available
     
     
     
230. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
     Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
     N Engl J Med. 2018;378:1573-1582.
     PubMed     Abstract available
     
     
     
231. BAIRD AE
     Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
     N Engl J Med. 2018;378:1635-1636.
     PubMed    
     
     
     
232. ZHAO YT, Huang YS
     ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
     N Engl J Med. 2018;378:e22.
     PubMed    
     
     
     
233. AMELOOT K, Daemen J, Van Mieghem N
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1360-1.
     PubMed    
     
     
     
234. PAPPALARDO F, Bertoldi L
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1360.
     PubMed    
     
     
     
235. PASCERI V, Pelliccia F, Speciale G
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1359-60.
     PubMed    
     
     
     
236. FERREIRA RM, Salis LHA, e Silva NAS
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1359.
     PubMed    
     
     
     
237. FLEISSNER F, Haverich A, Warnecke G
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1358-9.
     PubMed    
     
     
     
238. SHARMA S, Lardizabal J
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1358.
     PubMed    
     
     
     
239. 
     PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
     N Engl J Med. 2018;378:1358-1361.
     PubMed    
     
     
     March 2018
240. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
     Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
     N Engl J Med. 2018;378:1043-1053.
     PubMed    
     
     
     
241. WHITE WB, Saag KG, Becker MA, Borer JS, et al
     Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
     N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
     PubMed     Abstract available
     
     
     
242. LEE F, Maggiore P, Chung K
     Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
     N Engl J Med. 2018;378:960-962.
     PubMed    
     
     
     February 2018
243. 
     Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
     N Engl J Med. 2018;378:782.
     PubMed    
     
     
     January 2018
244. FAUCHIER L, Bisson A, Angoulvant D
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395.
     PubMed    
     
     
     
245. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
     Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
     N Engl J Med. 2018;378:345-353.
     PubMed     Abstract available
     
     
     
246. CAHILL TJ, Wijesurendra RS, Casadei B
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:397.
     PubMed    
     
     
     
247. HELFT G, Le Feuvre C, Zaman A
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:397.
     PubMed    
     
     
     
248. JEONG YH, Bae JS, Gurbel PA
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:396.
     PubMed    
     
     
     
249. AJANI AE
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395-6.
     PubMed    
     
     
     
250. 
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395-398.
     PubMed    
     
     
     
251. FAUCHIER L, Bisson A, Angoulvant D
     Rivaroxaban in Stable Cardiovascular Disease.
     N Engl J Med. 2018;378:395.
     PubMed    
     
     
     
252. WEBSTER MWI, Stables RH
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:299.
     PubMed    
     
     
     
253. SHAH R
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:299.
     PubMed    
     
     
     
254. VIJ A, Kodumuri V
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:298.
     PubMed    
     
     
     
255. BULLUCK H
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:298.
     PubMed    
     
     
     
256. 
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:298-301.
     PubMed    
     
     
     
257. STONE GW
     Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
     N Engl J Med. 2018;378:300-1.
     PubMed    
     
     
     
258. 
     Oxygen Therapy in Suspected Acute Myocardial Infarction.
     N Engl J Med. 2018;378:200-202.
     PubMed    
     
     
     
259. LELLOUCHE F, Simon M, L'Her E
     Oxygen Therapy in Suspected Acute Myocardial Infarction.
     N Engl J Med. 2018;378:201.
     PubMed    
     
     
     
260. SAMADANI U, Affana CK
     Oxygen Therapy in Suspected Acute Myocardial Infarction.
     N Engl J Med. 2018;378:200-1.
     PubMed    
     
     
     
261. ROSENBAUM L
     Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
     N Engl J Med. 2018;378:101-103.
     PubMed    
     
     
     December 2017
262. IMPRIALOS KP, Stavropoulos K, Doumas M
     Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2017;377:2502.
     PubMed    
     
     
     
263. HOLMAN RR, Bethel MA, Hernandez AF
     Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2017;377:2502.
     PubMed    
     
     
     
264. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
     Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
     N Engl J Med. 2017;377:2475-2484.
     PubMed    
     
     
     
265. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
     An Unusual Cause of Leg Pain.
     N Engl J Med. 2017;377:2267-2272.
     PubMed    
     
     
     November 2017
266. 
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2097-2099.
     PubMed    
     
     
     
267. RAJAGOPALAN S, Brook R
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2098-9.
     PubMed    
     
     
     
268. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2098.
     PubMed    
     
     
     
269. BAGLIONI P
     Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
     N Engl J Med. 2017;377:2097-8.
     PubMed    
     
     
     
270. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
     An Unusual Cause of Leg Pain.
     N Engl J Med. 2017;377:e29.
     PubMed    
     
     
     
271. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
     Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
     N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
     PubMed     Abstract available
     
     
     
272. JACOB KA, Gianoli M, van Dijk D
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1897-8.
     PubMed    
     
     
     
273. TAGGART DP, Puskas JD
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1897.
     PubMed    
     
     
     
274. JONES SG, Pullan MD, Kirmani BH
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1896-7.
     PubMed    
     
     
     
275. NOZAWA T, Imagawa T, Ito S
     Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
     N Engl J Med. 2017;377:1894-1896.
     PubMed    
     
     
     
276. 
     Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
     N Engl J Med. 2017;377:1898-1899.
     PubMed    
     
     
     October 2017
277. THIELE H, Akin I, Sandri M, Fuernau G, et al
     PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
     N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
     PubMed     Abstract available
     
     
     
278. MONTONE RA, Minelli S
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1595-6.
     PubMed    
     
     
     
279. AGGARWAL S, Pavlides G
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1595.
     PubMed    
     
     
     
280. BHATT DL
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1598-1599.
     PubMed    
     
     
     
281. DAVIES JE, Sen S, Escaned J
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1597-1598.
     PubMed    
     
     
     
282. PIJLS NHJ, De Bruyne B
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1596.
     PubMed    
     
     
     
283. 
     Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
     N Engl J Med. 2017;377:1596-7.
     PubMed    
     
     
     September 2017
284. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
     Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
     N Engl J Med. 2017;377:1217-1227.
     PubMed     Abstract available
     
     
     
285. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
     Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
     N Engl J Med. 2017;377:1119-1131.
     PubMed     Abstract available
     
     
     
286. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
     Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
     N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: